Literature DB >> 18342791

Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.

Paolo Anderlini, Nancy Swanston, Ashif Rashid, Carlos Bueso-Ramos, Homer A Macapinlac, Richard E Champlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18342791     DOI： 10.1016/j.bbmt.2007.12.496

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  5 in total

Review 1.  Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies.

Authors:  Antonia Rotolo; Anastasios Karadimitris; Marco Ruella
Journal:  Leuk Lymphoma       Date:  2017-11-22

Review 2.  Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.

Authors:  David Barrett; Jonathan D Fish; Stephan A Grupp
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

3.  Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma.

Authors:  A Raiola; A Dominietto; R Varaldo; A Ghiso; F Galaverna; S Bramanti; E Todisco; B Sarina; L Giordano; A Ibatici; A Santoro; M Clavio; A Bacigalupo; L Castagna
Journal:  Bone Marrow Transplant       Date:  2013-11-04       Impact factor: 5.483

Review 4.  Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma: Recent Advances and Outcomes.

Authors:  Taha Al-Juhaishi; Azra Borogovac; Sami Ibrahimi; Matthew Wieduwilt; Sairah Ahmed
Journal:  J Pers Med       Date:  2022-01-18

Review 5.  Haploidentical Stem Cell Transplantation in Lymphomas-Expectations and Pitfalls.

Authors:  Jacopo Mariotti; Stefania Bramanti; Armando Santoro; Luca Castagna
Journal:  J Clin Med       Date:  2020-11-07       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.